Page last updated: 2024-09-05

solifenacin succinate and tolterodine tartrate

solifenacin succinate has been researched along with tolterodine tartrate in 87 studies

Compound Research Comparison

Studies
(solifenacin succinate)
Trials
(solifenacin succinate)
Recent Studies (post-2010)
(solifenacin succinate)
Studies
(tolterodine tartrate)
Trials
(tolterodine tartrate)
Recent Studies (post-2010) (tolterodine tartrate)
522194343710258237

Research

Studies (87)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's31 (35.63)29.6817
2010's45 (51.72)24.3611
2020's11 (12.64)2.80

Authors

AuthorsStudies
Ikeda, K; Kobayashi, S; Miyata, K1
Araño, P; Bosch, JL; Chapple, CR; De Ridder, D; Kramer, AE; Ridder, AM1
Al-Shukri, S; Chapple, CR; Everaert, K; Huang, M; Meffan, P; Rechberger, T; Ridder, A1
Hatanaka, T; Ikeda, K; Kobayashi, S; Miyata, K; Ohtake, A; Sasamata, M; Sato, S; Ukai, M1
Sand, PK1
Hayashi, A; Noguchi, Y; Ohtake, A; Okutsu, H; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yoshino, T; Yuyama, H1
Bolodeoku, J; Chapple, CR; Drogendijk, T; Martinez-Garcia, R; Selvaggi, L; Toozs-Hobson, P; Warnack, W; Wright, DM1
Dmochowski, RR; Staskin, DR; Wein, AJ1
Jonas, U; Rackley, RR1
MacDiarmid, SA; Staskin, DR1
Appell, RA; McCrery, RJ; Smith, PP1
Goepel, M1
Brubaker, L; Chapple, C; Coyne, KS; Kopp, Z1
Hegde, SS; Michel, MC1
Hatanaka, T; Miyata, K; Noguchi, Y; Ohtake, A; Okutsu, H; Saitoh, C; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yuyama, H1
Chapple, C1
Bertozzi, R; Cipriani, S; Colli, E; Meschia, M; Montorsi, F; Olivieri, L; Parazzini, F1
Bolodeoku, J; Chapple, CR; Fianu-Jonsson, A; Indig, M; Khullar, V; Mistry, A; Rosa, J; Scarpa, RM; Wright, DM1
Chugh, A; Gupta, JB; Hegde, LG; Kumar, N; Meru, AV; Naruganahalli, KS; Ray, A; Sinha, S1
Hilas, O; Lam, S1
Marshall, T; Noe, L; Rasouliyan, L; Seifeldin, R; Zinner, N1
Bolodeoku, J; Khullar, V; Mundy, A; Odeyemi, I; Speakman, M1
Capo', JP; Chancellor, MB; Forero-Schwanhaeuser, S; Karram, M; Kobashi, K; Laramée, C; Nandy, I; Seifeldin, R; Siami, P; Snyder, JA; Whitmore, K; Zinner, N1
Burcher, E; Chandran, JJ; Christopoulos, A; Mansfield, KJ; Millard, RJ; Mitchelson, FJ; Vaux, KJ1
Ballarín, M; Balsa, D; Cabellos, J; Davalillo, S; Fernández, A; Lagunas, C; Pérez-Del-Pulgar, S; Salcedo, C1
Forero-Schwanhaeuser, S; Siami, P; Swift, SE1
Axelsen, S; Kulseng-Hansen, S; Mattiasson, A; Milsom, I; Nilsson, CG; Wickstrøm, J1
Iannazzo, S; Pradelli, L1
Altman, D; Falconer, C; Granath, F; Mattiasson, A1
Cardozo, L; Sidhu, M; Thorpe, A; Warner, J1
Wyndaele, JJ1
Fujino, T; Kageyama, A; Nozawa, Y; Yamada, S; Yoshida, A1
Chang, TC; Ho, CH; Huang, KH; Lin, HH; Liu, SP; Yu, HJ1
Capo', JP; Forero-Schwanhaeuser, S; He, W; Lucente, V1
Jakobsen, SM; Kersten, H; Molden, E1
Bungay, PJ; Callegari, E; Fenner, KS; Kay, GG; Kempshall, S; LaPerle, JL; Malhotra, B; Michel, MC; Webster, R1
Schröder, A; Thüroff, JW1
Chang, TC; Chen, CH; Hsiao, SM; Lin, HH; Wu, WY; Yu, HJ1
Chess-Williams, R; Moro, C; Uchiyama, J1
Cody, JD; Ellis, G; Hay-Smith, EJ; Herbison, GP; Madhuvrata, P1
Han, P; Liu, L; Luo, D; Shen, H; Wei, Q1
Kane, RL; Ramakrishnan, R; Sainfort, F; Shamliyan, T; Wyman, JF1
Alessandri, F; Candiani, M; Ferrero, S; Leone Roberti Maggiore, U; Origoni, M; Remorgida, V; Salvatore, S; Venturini, PL1
Jiang, XZ; Xu, C; Xu, ZS; Zhang, NZ; Zhao, HF1
Mauseth, SA; Skurtveit, S; Spigset, O1
Abrams, P; Hart, WM; Munro, V; Nazir, J; Retsa, P1
Akino, H; Fujiuchi, Y; Fuse, H; Kitagawa, Y; Miyazawa, K; Namiki, M; Suzuki, K; Yokoyama, O1
Arumi, D; Lizarraga, I; Miranda, P; Rejas, J; Sánchez-Ballester, F1
Aguado-Jodar, A; Ibáñez-Nolla, J; Kvasz, M; Navarro-Artieda, R; Rejas, J; Ruiz-Torrejón, A; Sicras-Mainar, A1
Aguado-Jodar, A; Navarro-Artieda, R; Rejas-Gutiérrez, J; Ruíz-Torrejón, A; Sicras-Mainar, A1
Chang, TC; Chen, CH; Hsiao, SM; Lin, HH; Su, TC1
Kosilov, KV; Kosilova, LV; Krasnykh, MA; Loparev, SA1
Chang, TC; Chen, CH; Hsiao, SM; Liao, SC; Lin, HH1
Blak, B; Hakimi, Z; Johnson, M; Nazir, J; Odeyemi, IA1
Li, J; Li, P; Liu, B; Wang, Y; Wu, Y1
Hakimi, Z; Heemstra, L; Ivanescu, C; Nazir, J; van Engen, A1
Barkin, J; Berner, T; Diles, D; Franks, B1
Coll-de Tuero, G; Navarro-Artieda, R; Ruiz-Torrejón, A; Sáez-Zafra, M; Sicras-Mainar, A2
Berner, T; Castro-Diaz, D; Kelleher, C; Nitti, VW; Siddiqui, E; Wagg, A1
Hsiao, SM; Kuo, HC; Lin, HH1
Dandolu, V; Lua, LL; Pathak, P1
Amri, I; Arbe, E; Bowditch, S; Drake, MJ; Guelfucci, F; Hakimi, Z; Nazir, J1
Aballéa, S; Hakimi, Z; Kelleher, C; Maman, K; Mankowski, C; Nazir, J; Odeyemi, I1
Cantrell, MA; Goodson, AB; Lund, BC; Shaw, RF1
Chang, HM; Chang, YC; Chen, HL; Chen, TC; Huang, WH; Juan, YS; Lee, HY; Pan, HF; Wang, YL; Wu, CM1
Abdel Moneim, MM; Belal, SF; El-Kimary, EI; Khamis, EF2
Brucker, BM; Peyronnet, B1
Gotoh, M; Hamada, T; Homma, Y; Igawa, Y; Kakizaki, H; Kobayashi, A; Kuroishi, K; Nishizawa, O; Okitsu, A; Seki, N; Takeda, M; Yamaguchi, O; Yokoyama, O; Yoshida, M1
Herbison, P; McKenzie, JE1
Cetinel, B; Dincer, M; Gultekin, MH; Guzelsoy, M; Onal, B; Turegun, FA1
Almeida, FG; Bernardo, WM; Sacomani, CAR; Silvinato, A1
Wang, HT; Xia, M1
Hansson, F; Kilany, S; Milsom, I; Schiotz, HA; Svensson, M1
Hamada, T; Igawa, Y; Kato, D; Katoh, T; Kuroishi, K; Yamaguchi, O1
Cardozo, L; Chapple, CR; Choudhury, N; Cruz, F; Heesakkers, J; Herschorn, S; Siddiqui, E; Staskin, D; Stoelzel, M1
Duong, V; Iglesia, C; Iwamoto, A; Kudish, B; Pennycuff, J1
Panicker, JN; Richardson, K; Welk, B1
Gomes, T; Herschorn, S; Jarvi, K; Juurlink, D; Matta, R; Nam, RK1
Ciesielski, K; Dancz, C; Latack, K; Morocco, E; Nguyen, B1
Cicione, A; DE Nunzio, C; DI Giacomo, F; Disabato, G; Franco, A; Gallo, G; Gravina, C; Lombardo, R; Nacchia, A; Rovesti, L; Trucchi, A; Tubaro, A; Turchi, B1
Fang, KW; Li, P; Wang, G; Xu, R; Yang, TX1
Deo, A; Dhamala, JN; Pradhan, T; Yadav, SK1
Hiren Prajapati, HP; Krunal Vishavadia, KV; Madhu Sharma, MS; Sandip Solanki, SS1

Reviews

24 review(s) available for solifenacin succinate and tolterodine tartrate

ArticleYear
Elevating our therapeutic expectations in overactive bladder.
    Journal of the American Academy of Nurse Practitioners, 2004, Volume: 16, Issue:10 Suppl

    Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Constipation; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia

2004
Using anticholinergics to treat overactive bladder: the issue of treatment tolerability.
    The American journal of medicine, 2006, Volume: 119, Issue:3 Suppl 1

    Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence

2006
The emergence of new drugs for overactive bladder.
    Expert opinion on emerging drugs, 2006, Volume: 11, Issue:1

    Topics: Acetylcholine; Amines; Animals; Anticonvulsants; Benzhydryl Compounds; Cresols; Cyclohexanecarboxylic Acids; Drug Evaluation, Preclinical; Gabapentin; gamma-Aminobutyric Acid; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Product Surveillance, Postmarketing; Quinuclidines; Randomized Controlled Trials as Topic; Receptor, Muscarinic M3; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Incontinence

2006
Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment.
    Urology, 2006, Volume: 68, Issue:2 Suppl

    Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Health Status; Humans; Mandelic Acids; Muscarinic Antagonists; Patient Compliance; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence, Stress

2006
Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?
    Naunyn-Schmiedeberg's archives of pharmacology, 2006, Volume: 374, Issue:2

    Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2006
Number of daytime micturitions and volume voided per micturition in the evaluation of efficacy of drugs for overactive bladder: findings from randomized clinical trials.
    European urology, 2007, Volume: 52, Issue:2

    Topics: Benzhydryl Compounds; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination

2007
Update on drugs for overactive bladder syndrome.
    Drug and therapeutics bulletin, 2007, Volume: 45, Issue:6

    Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2007
Pharmacologic management of overactive bladder.
    Clinical interventions in aging, 2007, Volume: 2, Issue:3

    Topics: Benzhydryl Compounds; Benzofurans; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2007
New strategies for medical management of overactive bladder in children.
    Current opinion in urology, 2010, Volume: 20, Issue:4

    Topics: Benzhydryl Compounds; Benzilates; Botulinum Toxins; Child; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quinuclidines; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination

2010
Which anticholinergic drug for overactive bladder symptoms in adults.
    The Cochrane database of systematic reviews, 2012, Jan-18, Volume: 1

    Topics: Adult; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence

2012
Solifenacin for overactive bladder: a systematic review and meta-analysis.
    International urogynecology journal, 2012, Volume: 23, Issue:8

    Topics: Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2012
Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review.
    Annals of internal medicine, 2012, Jun-19, Volume: 156, Issue:12

    Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Comparative Effectiveness Research; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence

2012
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.
    Expert opinion on drug metabolism & toxicology, 2012, Volume: 8, Issue:11

    Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Chronic Disease; Cresols; Drug Combinations; Female; Humans; Imidazoles; Mandelic Acids; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence

2012
[Safety of solifenacin and tolterodine in the treatment of overactive bladder: a meta-analysis].
    Zhonghua yi xue za zhi, 2012, Dec-25, Volume: 92, Issue:48

    Topics: Benzhydryl Compounds; Cresols; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2012
[Comparisons of therapeutic efficacy and safety of solifenacin versus tolterodine in patients with overactive bladder: a meta-analysis of outcomes].
    Zhonghua yi xue za zhi, 2014, Aug-13, Volume: 94, Issue:30

    Topics: Benzhydryl Compounds; Constipation; Cresols; Humans; Phenylpropanolamine; Quinuclidines; Safety; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Xerostomia

2014
Oral pharmacotherapy for overactive bladder in older patients: mirabegron as a potential alternative to antimuscarinics.
    Current medical research and opinion, 2016, Volume: 32, Issue:4

    Topics: Acetanilides; Administration, Oral; Adrenergic beta-Antagonists; Aged; Benzhydryl Compounds; Blood Pressure; Clinical Trials as Topic; Constipation; Female; Heart Rate; Humans; Male; Middle Aged; Muscarinic Antagonists; Prospective Studies; Retrospective Studies; Solifenacin Succinate; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive

2016
Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis.
    Neurourology and urodynamics, 2018, Volume: 37, Issue:3

    Topics: Benzhydryl Compounds; Benzilates; Humans; Mandelic Acids; Muscarinic Antagonists; Network Meta-Analysis; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2018
Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis.
    World journal of urology, 2018, Volume: 36, Issue:8

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Female; Humans; Hypertension; Male; Muscarinic Antagonists; Randomized Controlled Trials as Topic; Solifenacin Succinate; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive; Urological Agents

2018
Management of Overactive Bladder Symptoms After Radical Prostatectomy.
    Current urology reports, 2018, Oct-10, Volume: 19, Issue:12

    Topics: Botulinum Toxins, Type A; Humans; Male; Muscarinic Antagonists; Neuromuscular Agents; Postoperative Complications; Prostate; Prostatectomy; Solifenacin Succinate; Tolterodine Tartrate; Urethral Stricture; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urinary Incontinence, Stress

2018
Which anticholinergic is best for people with overactive bladders? A network meta-analysis.
    Neurourology and urodynamics, 2019, Volume: 38, Issue:2

    Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Humans; Imidazoles; Mandelic Acids; Network Meta-Analysis; Pyrrolidines; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2019
Comparisons of Therapeutic Efficacy and Safety of Solifenacin versus Tolterodine in Patients with Overactive Bladder: A Meta-Analysis.
    Urologia internationalis, 2019, Volume: 103, Issue:2

    Topics: Humans; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2019
A systematic review of neurocognitive dysfunction with overactive bladder medications.
    International urogynecology journal, 2021, Volume: 32, Issue:10

    Topics: Aged; Cognitive Dysfunction; Humans; Muscarinic Antagonists; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive

2021
The cognitive effect of anticholinergics for patients with overactive bladder.
    Nature reviews. Urology, 2021, Volume: 18, Issue:11

    Topics: Benzhydryl Compounds; Benzofurans; Cholinergic Antagonists; Cognition; Cognitive Dysfunction; Dementia; Humans; Mandelic Acids; Prodromal Symptoms; Pyrrolidines; Risk Assessment; Risk Factors; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive

2021
Efficacy, according to urodynamics, of OnabotulinumtoxinA compared with antimuscarinic drugs, for neurogenic detrusor overactivity: a systematic review and network meta-analysis.
    Scientific reports, 2022, 10-25, Volume: 12, Issue:1

    Topics: Bayes Theorem; Botulinum Toxins, Type A; Humans; Muscarinic Antagonists; Network Meta-Analysis; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Bladder, Overactive; Urodynamics

2022

Trials

16 trial(s) available for solifenacin succinate and tolterodine tartrate

ArticleYear
Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo- and tolterodine-controlled phase 2 dose-finding study.
    BJU international, 2004, Volume: 93, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Single-Blind Method; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Retention; Urination

2004
Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder.
    BJU international, 2004, Volume: 93, Issue:3

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urination Disorders

2004
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial.
    European urology, 2005, Volume: 48, Issue:3

    Topics: Analysis of Variance; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence

2005
Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg.
    European urology, 2007, Volume: 52, Issue:4

    Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Safety; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Stress; Urination

2007
Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER.
    Current medical research and opinion, 2008, Volume: 24, Issue:6

    Topics: Activities of Daily Living; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Health Services; Humans; Male; Middle Aged; Muscarinic Antagonists; Outcome Assessment, Health Care; Patient Acceptance of Health Care; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome.
    Current medical research and opinion, 2008, Volume: 24, Issue:8

    Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Double-Blind Method; Humans; Markov Chains; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study.
    Clinical therapeutics, 2008, Volume: 30, Issue:10

    Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2008
Diary and patient-reported outcomes in patients with severe overactive bladder switching from tolterodine extended release 4 mg/day to solifenacin treatment: An open-label, flexible-dosing, multicentre study.
    Clinical drug investigation, 2009, Volume: 29, Issue:5

    Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Quinuclidines; Severity of Illness Index; Solifenacin Succinate; Surveys and Questionnaires; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2009
Solifenacin and tolterodine are equally effective in the treatment of overactive bladder symptoms.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2010, Volume: 109, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Taiwan; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Urination

2010
Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome.
    The journal of obstetrics and gynaecology research, 2011, Volume: 37, Issue:8

    Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Female; Humans; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urodynamics

2011
[Treatment of overactive bladder in older women increased doses of antimuscarinic drugs safe and effective alternative to existing methods].
    Advances in gerontology = Uspekhi gerontologii, 2014, Volume: 27, Issue:1

    Topics: Aged; Benzhydryl Compounds; Benzilates; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics

2014
Psychometric assessment of female overactive bladder syndrome and antimuscarinics-related effects.
    Maturitas, 2014, Volume: 79, Issue:4

    Topics: Female; Humans; Linear Models; Middle Aged; Muscarinic Antagonists; Psychometrics; Quality of Life; Solifenacin Succinate; Surveys and Questionnaires; Tolterodine Tartrate; Urinary Bladder, Overactive; Women's Health

2014
Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study).
    International journal of urology : official journal of the Japanese Urological Association, 2019, Volume: 26, Issue:3

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Adult; Aged; Aged, 80 and over; Benzilates; Blood Pressure; Constipation; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imidazoles; Japan; Male; Middle Aged; Muscarinic Antagonists; Nasopharyngitis; Severity of Illness Index; Solifenacin Succinate; Thiazoles; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence; Xerostomia

2019
Which antimuscarinic agents used in the treatment of overactive bladder increase heart rate? a prospective randomized clinical trial.
    International urology and nephrology, 2019, Volume: 51, Issue:3

    Topics: Adult; Aged; Benzhydryl Compounds; Benzilates; Benzofurans; Blood Pressure; Female; Heart Rate; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Prospective Studies; Pyrrolidines; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive

2019
Cardiovascular safety of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A post hoc analysis from the Japanese MILAI II study.
    Lower urinary tract symptoms, 2020, Volume: 12, Issue:1

    Topics: Acetanilides; Aged; Aged, 80 and over; Benzilates; Cardiovascular Diseases; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imidazoles; Japan; Male; Middle Aged; Muscarinic Antagonists; Solifenacin Succinate; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2020
Safety and Efficacy of Mirabegron: Analysis of a Large Integrated Clinical Trial Database of Patients with Overactive Bladder Receiving Mirabegron, Antimuscarinics, or Placebo.
    European urology, 2020, Volume: 77, Issue:1

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Databases, Factual; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Solifenacin Succinate; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2020

Other Studies

47 other study(ies) available for solifenacin succinate and tolterodine tartrate

ArticleYear
Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells.
    Life sciences, 2004, Jan-02, Volume: 74, Issue:7

    Topics: Animals; Benzhydryl Compounds; Benzofurans; Calcium; Calcium Signaling; Carbachol; Cresols; Dose-Response Relationship, Drug; In Vitro Techniques; Inhibitory Concentration 50; Macaca fascicularis; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Submandibular Gland; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder

2004
In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats.
    European journal of pharmacology, 2004, May-25, Volume: 492, Issue:2-3

    Topics: Animals; Atropine; Benzhydryl Compounds; Benzofurans; Calcium; Cresols; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Mandelic Acids; Muscarinic Antagonists; Myocytes, Smooth Muscle; Organ Specificity; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Rats; Rats, Wistar; Solifenacin Succinate; Submandibular Gland; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder

2004
[Overactive bladder. New anticholinergic drug controls urinary urge].
    MMW Fortschritte der Medizin, 2004, Jul-08, Volume: 146, Issue:27-28

    Topics: Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence; Urodynamics

2004
Effects of solifenacin succinate (YM905) on detrusor overactivity in conscious cerebral infarcted rats.
    European journal of pharmacology, 2005, Apr-04, Volume: 512, Issue:1

    Topics: Animals; Benzhydryl Compounds; Benzilates; Cresols; Infarction, Middle Cerebral Artery; Male; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Quinuclidines; Rats; Rats, Sprague-Dawley; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Neurogenic

2005
Solifenacin versus tolterodine--a head-to-head study: finally! But not final?
    Current urology reports, 2005, Volume: 6, Issue:6

    Topics: Benzhydryl Compounds; Cresols; Double-Blind Method; Humans; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence

2005
Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome
    European urology, 2006, Volume: 49, Issue:1

    Topics: Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence

2006
[Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
    Der Urologe. Ausg. A, 2006, Volume: 45, Issue:7

    Topics: Analysis of Variance; Benzhydryl Compounds; Controlled Clinical Trials as Topic; Cresols; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence

2006
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
    Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:1

    Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Benzofurans; Binding, Competitive; Carbachol; CHO Cells; Cholinergic Agonists; Cresols; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Transfection; Urinary Bladder; Urinary Bladder, Overactive; Urination

2007
[Comment on the STAR study: Comparison of the efficacy and tolerance of solifenacin and tolterodine retard in the treatment of overactive bladder].
    Der Urologe. Ausg. A, 2007, Volume: 46, Issue:4

    Topics: Analysis of Variance; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2007
Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.
    European journal of pharmacology, 2007, Oct-31, Volume: 572, Issue:2-3

    Topics: Anesthesia; Animals; Benzhydryl Compounds; Benzofurans; Carbachol; Cholinergic Antagonists; Cresols; Injections, Intra-Arterial; Male; Mandelic Acids; Phenylpropanolamine; Pressure; Pyrrolidines; Quinuclidines; Rabbits; Salivary Glands; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder

2007
Comparison of receptor binding characteristics of commonly used muscarinic antagonists in human bladder detrusor and mucosa.
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 328, Issue:3

    Topics: Aged; Benzhydryl Compounds; Benzofurans; Cresols; Cystectomy; Female; Humans; Male; Middle Aged; Mucous Membrane; Muscarinic Antagonists; Phenylpropanolamine; Prostatectomy; Pyrrolidines; Quinuclidines; Quinuclidinyl Benzilate; Radioligand Assay; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive

2009
In vivo and in vitro pharmacological characterization of SVT-40776, a novel M3 muscarinic receptor antagonist, for the treatment of overactive bladder.
    British journal of pharmacology, 2009, Volume: 156, Issue:5

    Topics: Animals; Atrial Function; Benzhydryl Compounds; Benzofurans; Carbamates; Cresols; Guinea Pigs; In Vitro Techniques; Male; Mice; Muscle Contraction; Muscle, Smooth; Myocardial Contraction; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder

2009
Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countries.
    Acta obstetricia et gynecologica Scandinavica, 2009, Volume: 88, Issue:6

    Topics: Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Decision Support Techniques; Female; Finland; Humans; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Scandinavian and Nordic Countries; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
Solifenacin in the treatment of overactive bladder syndrome in Italian patients: pharmacoeconomic evaluation.
    Journal of medical economics, 2009, Volume: 12, Issue:1

    Topics: Benzhydryl Compounds; Computer Simulation; Cost-Benefit Analysis; Cresols; Humans; Italy; Markov Chains; Muscarinic Antagonists; Pharmacogenetics; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence

2009
Anticholinergic drug use for overactive bladder in Sweden: a nationwide pharmacoepidemiological study.
    International urogynecology journal and pelvic floor dysfunction, 2009, Volume: 20, Issue:11

    Topics: Benzhydryl Compounds; Benzofurans; Cholinergic Antagonists; Cresols; Female; Health Care Costs; Humans; Muscarinic Antagonists; Pharmacoepidemiology; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Registries; Retrospective Studies; Solifenacin Succinate; Sweden; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2009
The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service.
    BJU international, 2010, Volume: 106, Issue:4

    Topics: Benzhydryl Compounds; Benzilates; Cost-Benefit Analysis; Cresols; Decision Trees; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2010
Pediatrics: combining antimuscarinics shows promise for overactive bladder.
    Nature reviews. Urology, 2010, Volume: 7, Issue:2

    Topics: Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Pediatrics; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2010
Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis.
    Urology, 2010, Volume: 76, Issue:4

    Topics: Adenosine Triphosphate; Animals; Benzhydryl Compounds; Benzofurans; Cresols; Cystitis; Disease Models, Animal; Down-Regulation; Female; Hydrochloric Acid; Mandelic Acids; N-Methylscopolamine; Organophosphonates; Phenols; Phenylpropanolamine; Pirenzepine; Polycyclic Compounds; Pyridoxal Phosphate; Pyrrolidines; Quinuclidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Receptors, Purinergic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urination; Urodynamics

2010
Efficacy and tolerability of solifenacin in patients aged ≥ 65 years with overactive bladder: post-hoc analysis of 2 open-label studies.
    Postgraduate medicine, 2011, Volume: 123, Issue:1

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2011
Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay.
    Journal of the American Geriatrics Society, 2011, Volume: 59, Issue:3

    Topics: Benzhydryl Compounds; Benzofurans; Biological Assay; Brain; Cognition Disorders; Cresols; Humans; In Vitro Techniques; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate

2011
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.
    British journal of clinical pharmacology, 2011, Volume: 72, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Benzhydryl Compounds; Benzofurans; Blood-Brain Barrier; Brain; Cell Line; Chromatography, High Pressure Liquid; Cresols; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Solifenacin Succinate; Tandem Mass Spectrometry; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive

2011
Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.
    Urology, 2011, Volume: 78, Issue:6

    Topics: Animals; Atropine; Benzhydryl Compounds; Benzofurans; Carbachol; Cresols; Diamines; Mandelic Acids; Mucous Membrane; Muscarinic Antagonists; Muscle Contraction; Phenylpropanolamine; Piperidines; Pirenzepine; Pyrrolidines; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Stress, Mechanical; Swine; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urothelium

2011
Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: data from the Norwegian Prescription Database.
    Acta obstetricia et gynecologica Scandinavica, 2013, Volume: 92, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzofurans; Cholinergic Antagonists; Cresols; Databases, Pharmaceutical; Drug Substitution; Female; Follow-Up Studies; Humans; Medication Adherence; Middle Aged; Norway; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Young Adult

2013
Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom.
    Journal of medical economics, 2013, Volume: 16, Issue:10

    Topics: Benzhydryl Compounds; Cohort Studies; Cost-Benefit Analysis; Cresols; Humans; Incontinence Pads; Mandelic Acids; Markov Chains; Medication Adherence; Models, Economic; Muscarinic Antagonists; Patient Dropouts; Phenylpropanolamine; Quality-Adjusted Life Years; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urinary Incontinence

2013
Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: results of a real-life clinical study.
    International journal of urology : official journal of the Japanese Urological Association, 2014, Volume: 21, Issue:4

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Benzilates; Cresols; Cross-Sectional Studies; Female; Humans; Imidazoles; Japan; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive

2014
Therapeutic benefit in patients switching tolterodine to other novel antimuscarinic agents.
    Actas urologicas espanolas, 2014, Volume: 38, Issue:3

    Topics: Activities of Daily Living; Adult; Aged; Benzhydryl Compounds; Comorbidity; Cresols; Cross-Sectional Studies; Drug Substitution; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Observational Studies as Topic; Patient Preference; Patient Satisfaction; Personal Satisfaction; Phenylpropanolamine; Physicians; Propensity Score; Quinuclidines; Retrospective Studies; Sample Size; Solifenacin Succinate; Tetrahydroisoquinolines; Therapeutic Equivalency; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents; Young Adult

2014
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain.
    BMC urology, 2013, Oct-21, Volume: 13

    Topics: Aged; Benzhydryl Compounds; Cholinergic Agents; Cost-Benefit Analysis; Cresols; Female; Health Care Costs; Humans; Male; Phenylpropanolamine; Prevalence; Primary Health Care; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Spain; Syndrome; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents

2013
Use of health care resources and associated costs in non-institutionalized vulnerable elders with overactive bladder treated with antimuscarinic agents in the usual medical practice.
    Actas urologicas espanolas, 2014, Volume: 38, Issue:8

    Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Female; Health Care Costs; Health Resources; Humans; Male; Muscarinic Antagonists; Retrospective Studies; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive; Vulnerable Populations

2014
Autonomic dysfunction and arterial stiffness in female overactive bladder patients and antimuscarinics related effects.
    Maturitas, 2014, Volume: 79, Issue:1

    Topics: Adult; Ankle Brachial Index; Blood Pressure; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Middle Aged; Muscarinic Antagonists; Nocturia; Pressure; Solifenacin Succinate; Tolterodine Tartrate; Urethra; Urinary Bladder, Overactive; Urinary Incontinence; Urination; Urodynamics; Vascular Stiffness

2014
Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
    Current medical research and opinion, 2015, Volume: 31, Issue:1

    Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Family Practice; Humans; Lower Urinary Tract Symptoms; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Primary Health Care; Prostatic Hyperplasia; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Tolterodine Tartrate; United Kingdom

2015
Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    BMC urology, 2015, May-09, Volume: 15

    Topics: Administration, Oral; Aged; Aged, 80 and over; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Combinations; Drug Therapy, Combination; Follow-Up Studies; Humans; Lower Urinary Tract Symptoms; Male; Markov Chains; Middle Aged; Prostatic Hyperplasia; Severity of Illness Index; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Treatment Outcome; Urodynamics

2015
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
    The Canadian journal of urology, 2015, Volume: 22, Issue:4

    Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate

2015
Impact of Loss of Work Productivity in Patients with Overactive Bladder Treated with Antimuscarinics in Spain: Study in Routine Clinical Practice Conditions.
    Clinical drug investigation, 2015, Volume: 35, Issue:12

    Topics: Adult; Benzhydryl Compounds; Female; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Primary Health Care; Retrospective Studies; Sick Leave; Solifenacin Succinate; Spain; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Work Performance

2015
Persistence and concomitant medication in patients with overactive bladder treated with antimuscarinic agents in primary care. An observational baseline study.
    Actas urologicas espanolas, 2016, Volume: 40, Issue:2

    Topics: Benzhydryl Compounds; Female; Humans; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Primary Health Care; Retrospective Studies; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive

2016
Treatment Outcome of Overactive Bladder Patients Receiving Antimuscarinic Therapy for More than One Year.
    Lower urinary tract symptoms, 2018, Volume: 10, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Constipation; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Retrospective Studies; Severity of Illness Index; Solifenacin Succinate; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Vision Disorders; Xerostomia; Young Adult

2018
Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents.
    Neurourology and urodynamics, 2017, Volume: 36, Issue:8

    Topics: Adolescent; Adult; Cholinergic Antagonists; Female; Humans; Male; Mandelic Acids; Medication Adherence; Middle Aged; Obesity; Quality of Life; Sex Factors; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive; Young Adult

2017
A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands.
    BMC urology, 2017, May-22, Volume: 17, Issue:1

    Topics: Adrenergic alpha-Antagonists; Aged; Cohort Studies; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Medication Adherence; Middle Aged; Muscarinic Antagonists; Netherlands; Prostatic Hyperplasia; Retrospective Studies; Solifenacin Succinate; Tolterodine Tartrate

2017
Comparative Effectiveness of Anticholinergic Agents for Lower Urinary Tract Symptoms.
    Journal of managed care & specialty pharmacy, 2018, Volume: 24, Issue:1

    Topics: Age Factors; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Comorbidity; Diabetes Mellitus; Female; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Multiple Sclerosis; Parkinson Disease; Retrospective Studies; Sex Factors; Solifenacin Succinate; Tolterodine Tartrate; United States; United States Department of Veterans Affairs

2018
Enhanced spectrofluorimetric determination of two novel combination therapies for the treatment of benign prostatic hyperplasia containing tamsulosin hydrochloride.
    Luminescence : the journal of biological and chemical luminescence, 2018, Volume: 33, Issue:4

    Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Molecular Structure; Prostatic Hyperplasia; Solifenacin Succinate; Spectrometry, Fluorescence; Sulfonamides; Tamsulosin; Tolterodine Tartrate

2018
Overactive bladder - pharmacological treatment.
    Revista da Associacao Medica Brasileira (1992), 2019, May-02, Volume: 65, Issue:4

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Antidepressive Agents; Benzilates; Benzofurans; Brazil; Clinical Decision-Making; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Pyrrolidines; Solifenacin Succinate; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive

2019
A Nordic registry-based study of drug treatment patterns in overactive bladder patients.
    Scandinavian journal of urology, 2019, Volume: 53, Issue:4

    Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzofurans; Denmark; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Norway; Practice Patterns, Physicians'; Prospective Studies; Pyrrolidines; Registries; Solifenacin Succinate; Sweden; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive

2019
Fourier convolution versus derivative spectrophotometry: Application to the analysis of two binary mixtures containing tamsulosin hydrochloride as a minor component.
    Annales pharmaceutiques francaises, 2020, Volume: 78, Issue:2

    Topics: Calibration; Capsules; Drug Combinations; Reference Standards; Reproducibility of Results; Solifenacin Succinate; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Tablets; Tamsulosin; Tolterodine Tartrate

2020
Receipt of Overactive Bladder Drugs and Incident Dementia: A Population-based Case-control Study.
    European urology focus, 2022, Volume: 8, Issue:5

    Topics: Aged; Canada; Case-Control Studies; Dementia; Humans; Muscarinic Antagonists; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive

2022
Patient Experience of Antimuscarinic Treatment for Overactive Bladder: A Qualitative Exploration of Online Forum Content.
    Female pelvic medicine & reconstructive surgery, 2022, 03-01, Volume: 28, Issue:3

    Topics: Female; Humans; Male; Muscarinic Antagonists; Patient Outcome Assessment; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive

2022
Adverse events related to antimuscarinics and beta-3-agonist: "real-life" data from the Eudra-Vigilance Database.
    Minerva urology and nephrology, 2022, Volume: 74, Issue:6

    Topics: Aged; Aged, 80 and over; Female; Humans; Hypertension; Male; Muscarinic Antagonists; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Retention

2022
Patient Perception of Bladder Condition after Treatment with Solifenacin and Tolterodine in Overactive Bladder Patients.
    Journal of Nepal Health Research Council, 2023, Mar-10, Volume: 20, Issue:3

    Topics: Benzhydryl Compounds; Cresols; Cross-Sectional Studies; Humans; Nepal; Perception; Phenylpropanolamine; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder, Overactive

2023
[Assessment of prescribing practices in overactive bladder pharmacotherapy across different specialties of India: a prescription trend analysis].
    Urologiia (Moscow, Russia : 1999), 2023, Issue:2

    Topics: Acetanilides; Humans; Muscarinic Antagonists; Prescriptions; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive; Urological Agents

2023